Precise Design of TiO2@CoOx Heterostructure via Atomic Layer Deposition for Synergistic Sono-Chemodynamic Oncotherapy

Wen Liu, Runrun Shao, Lingyun Guo, Jianliang Man, Chengwu Zhang, Lihong Li, Haojiang Wang, Bin Wang, Lixia Guo, Sufang Ma, Bin Zhang, Haipeng Diao, Yong Qin, Lili Yan

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Sonodynamic therapy (SDT), a tumor treatment modality with high tissue penetration and low side effects, is able to selectively kill tumor cells by producing cytotoxic reactive oxygen species (ROS) with ultrasound-triggered sonosensitizers. N-type inorganic semiconductor TiO2 has low ROS quantum yields under ultrasound irradiation and inadequate anti-tumor activity. Herein, by using atomic layer deposition (ALD) to create a heterojunction between porous TiO2 and CoOx, the sonodynamic therapy efficiency of TiO2 can be improved. Compared to conventional techniques, the high controllability of ALD allows for the delicate loading of CoOx nanoparticles into TiO2 pores, resulting in the precise tuning of the interfaces and energy band structures and ultimately optimal SDT properties. In addition, CoOx exhibits a cascade of H2O2→O2→·O2 in response to the tumor microenvironment, which not only mitigates hypoxia during the SDT process, but also contributes to the effect of chemodynamic therapy (CDT). Correspondingly, the synergistic CDT/SDT treatment is successful in inhibiting tumor growth. Thus, ALD provides new avenues for catalytic tumor therapy and other pharmaceutical applications.

Original languageEnglish
Article number2304046
JournalAdvanced Science
Volume11
Issue number14
DOIs
StatePublished - 10 Apr 2024
Externally publishedYes

Keywords

  • atomic layer deposition
  • carrier separation efficiency improvement
  • energy band structure adaptation
  • heterostructure
  • synergistic sono-chemodynamic oncotherapy

Fingerprint

Dive into the research topics of 'Precise Design of TiO2@CoOx Heterostructure via Atomic Layer Deposition for Synergistic Sono-Chemodynamic Oncotherapy'. Together they form a unique fingerprint.

Cite this